Multiple Sclerosis Center of Northeastern New York
Quick facts
Marketed products
- BG00012 (DMF) (Tecfidera®.) · Neurology; Immunology
BG00012 (dimethyl fumarate) activates the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway to reduce oxidative stress and modulate immune responses in the central nervous system. - incabotulinumtoxinA · Neurology
IncabotulinumtoxinA is a botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Multiple Sclerosis Center of Northeastern New York portfolio CI brief
- Multiple Sclerosis Center of Northeastern New York pipeline updates RSS
Frequently asked questions about Multiple Sclerosis Center of Northeastern New York
What are Multiple Sclerosis Center of Northeastern New York's marketed drugs?
Top marketed products include BG00012 (DMF) (Tecfidera®.), incabotulinumtoxinA.
Related
- BG00012 (DMF) (Tecfidera®.) · Neurology; Immunology
- incabotulinumtoxinA · Neurology
- Sector hub: All tracked pharma companies